Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 21, 2020; 26(39): 6037-6046
Published online Oct 21, 2020. doi: 10.3748/wjg.v26.i39.6037
Table 1 Clinicopathological data of esophageal and gastric cancer patients with metastatic disease
Esophageal carcinoma
Gastric adenocarcinoma
AC
SCC
Intestinal-type AC
Diffuse-type AC
n = 167
n = 101
n = 209
n = 122
Sex
Female31 (18.6%)32 (31.7%)54 (25.8%)50 (41.0%)
Men136 (81.4%)69 (68.3%)155 (74.2%)72 (59.0%)
Year of diagnosis
1987-199324 (14.4%)20 (19.8%)40 (19.1%)22 (18.0%)
1994-199938 (22.8%)30 (29.7%)69 (33.0%)28 (23.0%)
2000-200528 (16.8%)19 (18.8%)41 (19.6%)23 (18.9%)
2006-201134 (20.4%)17 (16.8%)30 (14.4%)20 (16.4%)
2011-201743 (25.7%)15 (14.9%)29 (13.9%)29 (23.8%)
Mean age at diagnosis (years)66646964
Mean age at death (years)67657065
Location of primary tumor
Proximal1 (0.6%)12 (11.9%)73 (34.9%)29 (23.8%)
Mid2 (1.2%)10 (9.9%)25 (12.0%)20 (16.4%)
Distal132 (79.0%)42 (41.6%)43 (20.6%)18 (14.8%)
NOS32 (19.2%)37 (36.6%)68 (32.5%)44 (36.1%)
Linitis plastica---11 (9.0%)